Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock

被引:14
作者
Bauer, Seth R. [1 ]
Sacha, Gretchen L. [1 ]
Lam, Simon W. [1 ]
机构
[1] Cleveland Clin, Dept Pharm, Cleveland, OH 44106 USA
来源
PHARMACOTHERAPY | 2018年 / 38卷 / 08期
关键词
drug-related side effects and adverse reactions; vasopressin; angiotensin II; shock; septic;
D O I
10.1002/phar.2147
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Circulatory shock is a medical emergency that requires rapid intervention to optimize patient outcomes. Although catecholamine vasopressors are considered life-sustaining therapy, they are associated with adverse reactions, and vasopressin and angiotensin II may be used to minimize these adverse effects. However, vasopressin and angiotensin II are also associated with adverse reactions that must be known to the clinician to mitigate risk for patients. This review focuses on the known adverse drug effects of vasopressin and angiotensin II while offering potential solutions to minimize harm with these agents. Future directions with vasoactive medication safety including optimization of the electronic medical record, clinical decision support, prediction analytics, and precision medicine for patients with circulatory shock are also discussed.
引用
收藏
页码:851 / 861
页数:11
相关论文
共 76 条
  • [71] U. S. Food and Drug Administration Center for Drug Evalua-tion and Research, 2014, VAS 204485OR1S000 ME
  • [72] U. S. Food and Drug Administration Center for Drug Evaluation and Research, 2017, ANG 2 29360ORIG1S000
  • [73] Development, Implementation, and Impact of an Automated Early Warning and Response System for Sepsis
    Umscheid, Craig A.
    Betesh, Joel
    VanZandbergen, Christine
    Hanish, Asaf
    Tait, Gordon
    Mikkelsen, Mark E.
    French, Benjamin
    Fuchs, Barry D.
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2015, 10 (01) : 26 - 31
  • [74] Vasovski M, 2009, CRIT CARE MED, V37, pA412
  • [75] Angiotensin II in experimental hyperdynamic sepsis
    Wan, Li
    Langenberg, Christoph
    Bellomo, Rinaldo
    May, Clive N.
    [J]. CRITICAL CARE, 2009, 13 (06): : R190
  • [76] Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock
    Wu, Janet Y.
    Stollings, Joanna L.
    Wheeler, Arthur P.
    Semler, Matthew W.
    Rice, Todd W.
    [J]. ANNALS OF PHARMACOTHERAPY, 2017, 51 (01) : 13 - 20